444 related articles for article (PubMed ID: 38249745)
1. Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer's disease, and epilepsy.
Martin SP; Leeman-Markowski BA
Front Neurol; 2023; 14():1287545. PubMed ID: 38249745
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies.
Tsitsopoulos PP; Marklund N
Front Neurol; 2013; 4():79. PubMed ID: 23805125
[TBL] [Abstract][Full Text] [Related]
3. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
4. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
Tran HT; LaFerla FM; Holtzman DM; Brody DL
J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
[TBL] [Abstract][Full Text] [Related]
5. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.
Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E
Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108
[TBL] [Abstract][Full Text] [Related]
6. Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE).
VanItallie TB
Metabolism; 2019 Nov; 100S():153943. PubMed ID: 31610856
[TBL] [Abstract][Full Text] [Related]
7. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
8. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Laurent C; Buée L; Blum D
Biomed J; 2018 Feb; 41(1):21-33. PubMed ID: 29673549
[TBL] [Abstract][Full Text] [Related]
9. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori K; Uchida T
J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
[TBL] [Abstract][Full Text] [Related]
10. The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death.
Thal DR; Tomé SO
Brain Res Bull; 2022 Nov; 190():204-217. PubMed ID: 36244581
[TBL] [Abstract][Full Text] [Related]
11. Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.
Alyenbaawi H; Kanyo R; Locskai LF; Kamali-Jamil R; DuVal MG; Bai Q; Wille H; Burton EA; Allison WT
Elife; 2021 Feb; 10():. PubMed ID: 33527898
[TBL] [Abstract][Full Text] [Related]
12. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.
Rueli RH; Torres DJ; Dewing AS; Kiyohara AC; Barayuga SM; Bellinger MT; Uyehara-Lock JH; White LR; Moreira PI; Berry MJ; Perry G; Bellinger FP
J Alzheimers Dis; 2017; 55(2):749-762. PubMed ID: 27802219
[TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
14. Neurobiology of Alzheimer's disease.
Mohandas E; Rajmohan V; Raghunath B
Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
[TBL] [Abstract][Full Text] [Related]
16. A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease.
Islam Khan R; Nirzhor SSR; Rashid B
Brain Sci; 2018 Aug; 8(9):. PubMed ID: 30149687
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta and tau pathology following repetitive mild traumatic brain injury.
Edwards G; Moreno-Gonzalez I; Soto C
Biochem Biophys Res Commun; 2017 Feb; 483(4):1137-1142. PubMed ID: 27492070
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.
Rawat P; Sehar U; Bisht J; Selman A; Culberson J; Reddy PH
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361631
[TBL] [Abstract][Full Text] [Related]
20. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
